Cold, Flu and Allergy Remedies - US

Published by: Mintel International Group Ltd.

Published: Oct. 1, 2007 - 95 Pages

Table of Contents

Scope and Themes

What you need to know

Definition

Consumer research methodology

Abbreviations and terms

Abbreviations

Terms

Executive Summary

Sales driven by incidence, population factors

A healthy market boosted by Rx switches and new product launches

Tablets lead market as liquids slip and nasal products gain ground

Mergers consolidate supply structure

Ad & promo

Professional staff drive sales to drug channel—even for common cold and allergy remedies

The consumer

Incidence of ailments and usage of remedies

Attitudes towards CF&A remedies

The ethnic consumer

What the future holds

Market Drivers

Incidence of cold, flu, and allergies

Key points

Details

Figure 1: Severity of flu (only), October 2006

Figure 2: Severity of nasal allergies/hay fever (only), October 2006

Seasonal severity

Figure 3: Influenza seasonal severity, in the U.S., 2000-06

Higher contraction risk among children, women, elderly

Figure 4: Population by age, 2002-12

Figure 5: Population of OTC flu remedy users, based on those confirmed to have the flu, by gender, 2002-12

Rx switches boost sales

Uninsured turn to self-care, diagnosis

Shift of pseudoephedrine to behind the counter

Alternative remedies cut into OTC sales

Vaccines and Rx remedies compete with OTC

Figure 6: Preference for OTC vs. Rx cold, flu, and allergy remedies, October 2006

Market Size and Trends

Market size

Figure 7: Total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07

Wal-Mart estimate

Market trends

Multi-symptom relief

Flavor

Natural/organic ingredients

Market Segmentation

Cold, flu, and allergy remedy segments

Figure 8: FDM sales of cold, flu, and allergy remedies, segmented by delivery form, 2005 and 2007

Tablets

Figure 9: Sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2002-07

Liquids

Figure 10: Sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2002-07

Nasal products

Figure 11: Sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2002-07

Supply Structure

Introduction

Companies and brands

Figure 12: Manufacturer FDM sales of cold, flu, and allergy remedies in the U.S., 2005 and 2007

Tablets

Figure 13: Manufacturer brand sales of cold, flu, and allergy remedy tablets, in the U.S., 2005 and 2007

Liquids

Figure 14: Manufacturer brand sales of cold, flu, and allergy remedy liquids, in the U.S., 2005 and 2007

Nasal products

Figure 15: Manufacturer brand sales of cold, flu, and allergy remedy nasal products, in the U.S., 2005 and 2007

Advertising and Promotion

Introduction

Figure 16: Promotional expenditures of the top CF&A manufacturers*, 2005-06

Television marketing campaigns

Schering-Plough

Figure 17: Corocidin TV spot—high blood pressure-safe

Pfizer, Inc.

Figure 18: PediaCare liquid TV spot—pediatrician-endorsed

Figure 19: Sudacare Shower Soother and Sudacare Vapor Plug TV spot—non-medicated

Figure 20: Sudacare Shower Soother TV spot—non-medicated

Procter & Gamble

Figure 21: Vicks NyQuil and Vicks DayQuil TV spot—fast relief

Figure 22: Vicks NyQuil TV spot—tried and true

McNeil

Figure 23: Children’s Motrin liquid TV spot—pediatrician-endorsed

Figure 24: Tylenol Cold Multi-Symptom TV spot—multi-symptom; comparative advertising

Figure 25: Children’s Tylenol Plus Cold TV spot—multi-symptom; doctor-recommended

Adams Respiratory Therapeutics

Figure 26: Mucinex DM TV spot—memorable character

Wyeth Labs, Inc.

Figure 27: Advil TV spot—multi-symptom relief

Figure 28: Robitussin TV spot—wide product range

Novartis

Figure 29: TheraFlu Warming relief TV spot—restorative

Figure 30: Triaminic Nighttime Cold & Cough TV spot—child-friendly advertising

Other companies

Figure 31: Zicam TV spot—consumer testimonial

Figure 32: Zicam Cough Max TV spot—convenience

Figure 33: Alka-Seltzer Plus liquid TV spot—multi-symptom relief

Figure 34: Aleve cold/sinus TV spot—“real people;” circumvents pseudoephedrine restrictions

Retail Distribution

Introduction

Figure 35: U.S. FDM and convenience store retail sales of cold, flu, and allergy remedies, by channel, 2005 and 2007

Drug stores

Figure 36: U.S. drug store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07

Supermarkets

Figure 37: U.S. supermarket sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07

Mass merchandisers

Figure 38: U.S. mass merchandiser sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07

Convenience stores

Figure 39: U.S. convenience store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07

The Consumer: Use of Cold, Flu, and Allergy Remedies

Summary

Incidence of ailments, usage of remedies

Incidence of flu and allergies

Figure 40: Incidence of flu and nasal allergies/hay fever, by age, January-October 2006

Severity of flu and nasal allergies/hay fever

Figure 41: Severity of flu and nasal allergies/hay fever, by age, January-October 2006

Use of cold, flu, and sinus remedies

Figure 42: Use of cold, flu, and allergy remedies, by age, January-October 2006

Preferred brands of cold, flu, and allergy remedies

Figure 43: Preferred brands of cold, flu, and allergy remedies, by age, January-October 2006

Frequency of usage of cold, flu, and allergy remedies

Figure 44: Frequency of usage of cold, flu, and allergy remedies, by age, January-October 2006

OTC vs. Rx cold, flu, and allergy remedies

Figure 45: Preference for OTC vs. Rx cold, flu, and allergy remedies, by age, January-October 2006

Ailments treated with cold, flu, and allergy remedies

Figure 46: Ailments treated with cold, flu, and allergy remedies, by age, January-October 2006

Household usage of children’s cold, flu, and allergy remedies

Figure 47: Household usage of children’s cold, flu, and allergy remedies, January-October 2006

Types and brands of children’s remedies preferred among households

Figure 48: Household preference for types and brands of children’s cold, flu, and allergy remedies, January-October 2006

Teen use of cold, flu, and allergy remedies

Figure 49: Teen use of cold, flu, and allergy remedies, by gender and age, January-October 2006

The Consumer: Attitudes towards Cold, Flu, and Allergy Remedies and Their Side Effects

Summary

Attitudes towards cold, flu, and allergy remedies

Figure 50: Attitudes towards cold, flu, and allergy remedies, by gender, August 2007

Figure 51: Attitudes towards cold, flu, and allergy remedies, by age, August 2007

Figure 52: Attitudes towards cold, flu, and allergy remedies, by number of children in household, August 2007

Side effects from cold, flu, allergy remedies

Figure 53: cold, flu, and allergy remedy side effects experienced in the past 12 months, by age, August 2007

The Consumer: Ethnic Use of Cold, Flu, and Allergy Remedies

Summary

Incidence of ailments, usage of remedies among ethnicities

Incidence of flu and allergies among ethnicities

Figure 54: Incidence of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006

Severity of flu and nasal allergies/hay fever among ethnicities

Figure 55: Severity of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006

Preferred formulations of cold, flu, and allergy remedies among ethnicities

Figure 56: Preference for 4-6-hour or 12-hour cold, flu, and allergy remedies, by race/ethnicity, January-October 2006

Preferred brands of cold, flu, and allergy remedies among ethnicities

Figure 57: Preferred brands of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006

Frequency of usage of cold, flu, and allergy remedies among ethnicities

Figure 58: Frequency of usage of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006

OTC vs. Rx cold, flu, and allergy remedies preferences among ethnicities

Figure 59: Preference for OTC vs. Rx cold, flu, and allergy remedies, by race/ethnicity, January-October 2006

Ailments ethnicities treat with cold, flu, and allergy remedies

Figure 60: Ailments treated with cold, flu, and allergy remedies, by race/ethnicity, January-October 2006

Attitudes towards cold, flu, and allergy remedies among ethnicities

Figure 61: Attitudes towards cold, flu, and allergy remedies, by race/ethnicity, August 2007

Side effects from cold, flu, allergy remedies experienced among ethnicities

Figure 62: cold, flu, and allergy remedy side effects experienced in the past 12 months, by race/ethnicity, August 2007

Future and Forecast

Future trends

OTC switch of Zyrtec promises market boost

FDA advisory panel advises against children’s cough and cold remedies; manufacturers pull infants’ remedies

Market forecast

Cold, flu, and allergy remedies

Figure 63: Forecast of total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2007-12

Cold, flu, and allergy remedy tablets

Figure 64: Forecast of U.S. FDM sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2007-12

Cold, flu, and allergy remedy liquids

Figure 65: Forecast of U.S. FDM sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2007-12

Cold, flu, and allergy remedy nasal products

Figure 66: Forecast of U.S. FDM sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2007-12

Forecast factors

Appendix: Trade Associations

Abstract

The U.S. cold, flu, and allergy remedies market relies heavily on new product innovation. Greatly influenced by seasonal rhythms and the rising cost of healthcare, the market changes dramatically with changes in vaccines and in the prescription market.

This report will help you understand:

• The huge impact of prescription to over-the-counter switches in tablets, including Claritin and the impending migration of Zyrtec.
• The effect of the 2006 Stop Meth Act, which moved pseudoephedrine products behind the counter, inconveniencing customers and highlighting potential dangers of over-the-counter remedies.
• Activity from the seven leading remedy manufacturers, and the effect of the Johnson & Johnson/Pfizer merger on the supply chain and advertising/promotional strategies.
• The retail landscape, dominated by the drug channel, and the attempts of food and mass channels to adopt similar pharmaceutical services.
• Close inspection of consumer behavior regarding remedies and the conditions they treat, yielding ideas about how manufacturers can increase usage and penetration.

Moreover, this report features in-depth analysis of the future of the market, including potential of and competition from alternative remedies; the impact of voluntary withdrawal of infants’ remedies; and the threat of FDA findings which may limit or stop sales of children’s remedies.

Not covered in this report are lozenges, medicated sweets, and products for the relief of coughs and sore throats.
Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.